Environment factors, DNA methylation, and cancer

被引:19
作者
Liu, Jie [1 ,2 ]
Huang, Binjie [1 ,2 ]
Ding, Feifei [1 ,2 ]
Li, Yumin [1 ,2 ]
机构
[1] Lanzhou Univ, Dept Gen Surg, Hosp 2, Lan Zhou, Peoples R China
[2] Lanzhou Univ, Key Lab Digest Syst Tumors Gansu Prov, Hosp 2, Lan Zhou, Peoples R China
关键词
DNA methylation; Environment; Cancer; Epigenetics; Prevention; TUMOR-SUPPRESSOR GENES; POLYCYCLIC AROMATIC-HYDROCARBONS; CPG ISLAND METHYLATION; ONE-CARBON METABOLISM; UMBILICAL-CORD BLOOD; COLORECTAL-CANCER; PROMOTER METHYLATION; HELICOBACTER-PYLORI; GASTRIC-CANCER; ALCOHOL-CONSUMPTION;
D O I
10.1007/s10653-023-01749-8
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Today, the rapid development of science and technology and the rapid change in economy and society are changing the way of life of human beings and affecting the natural, living, working, and internal environment on which human beings depend. At the same time, the global incidence of cancer has increased significantly yearly, and cancer has become the number one killer that threatens human health. Studies have shown that diet, living habits, residential environment, mental and psychological factors, intestinal flora, genetics, social factors, and viral and non-viral infections are closely related to human cancer. However, the molecular mechanisms of the environment and cancer development remain to be further explored. In recent years, DNA methylation has become a key hub and bridge for environmental and cancer research. Some environmental factors can alter the hyper/hypomethylation of human cancer suppressor gene promoters, proto-oncogene promoters, and the whole genome, causing low/high expression or gene mutation of related genes, thereby exerting oncogenic or anticancer effects. It is expected to develop early warning markers of cancer environment based on DNA methylation, thereby providing new methods for early detection of cancers, diagnosis, and targeted therapy. This review systematically expounds on the internal mechanism of environmental factors affecting cancer by changing DNA methylation, aiming to help establish the concept of cancer prevention and improve people's health.
引用
收藏
页码:7543 / 7568
页数:26
相关论文
共 50 条
  • [41] The Roles of DNA Methylation in the Stages of Cancer
    McMahon, K. Wyatt
    Karunasena, Enusha
    Ahuja, Nita
    CANCER JOURNAL, 2017, 23 (05) : 257 - 261
  • [42] Methylation and ovarian cancer: Can DNA methylation be of diagnostic use?
    Hentze, Julie L.
    Hogdall, Claus K.
    Hogdall, Estrid V.
    MOLECULAR AND CLINICAL ONCOLOGY, 2019, 10 (03) : 323 - 330
  • [43] Role of DNA methylation in renal cell carcinoma
    Shenoy, Niraj
    Vallumsetla, Nishanth
    Zou, Yiyu
    Galeas, Jose Nahun
    Shrivastava, Makardhwaj
    Hu, Caroline
    Susztak, Katalin
    Verma, Amit
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2015, 8
  • [44] DNA methylation and cancer
    Peter A Jones
    Oncogene, 2002, 21 : 5358 - 5360
  • [45] DNA Methylation and Cancer
    Kulis, Marta
    Esteller, Manel
    EPIGENETICS AND CANCER, PT A, 2010, 70 : 27 - 56
  • [46] METHYLATION OF DNA IN CANCER
    Watanabe, Yoshihisa
    Maekawa, Masato
    ADVANCES ON CLINICAL CHEMISTRY, VOL 52, 2010, 52 : 145 - 167
  • [47] DNA Methylation Based Biomarkers in Non-Invasive Cancer Screening
    Shivapurkar, N.
    Gazdar, A. F.
    CURRENT MOLECULAR MEDICINE, 2010, 10 (02) : 123 - 132
  • [48] DNA methylation biomarkers in colorectal cancer: Clinical applications for precision medicine
    Fatemi, Nayeralsadat
    Tierling, Sascha
    Es, Hamidreza Aboulkheyr
    Varkiani, Maryam
    Mojarad, Ehsan Nazemalhosseini
    Aghdaei, Hamid Asadzadeh
    Walter, Joern
    Totonchi, Mehdi
    INTERNATIONAL JOURNAL OF CANCER, 2022, 151 (12) : 2068 - 2081
  • [49] Application of artificial neural networks to link genetic and environmental factors to DNA methylation in colorectal cancer
    Coppede, Fabio
    Grossi, Enzo
    Lopomo, Angela
    Spisni, Roberto
    Buscema, Massimo
    Migliore, Lucia
    EPIGENOMICS, 2015, 7 (02) : 175 - 186
  • [50] DNA methylation and cancer
    Jones, PA
    ONCOGENE, 2002, 21 (35) : 5358 - 5360